Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: results from the GEOMETRY mono-1 study

J. Wolf; E. B. Garon; D. S. -W Tan; H. J. M. Groen; T. Seto; E. F. Smit; M. Zou; Y. Yang; Y. Li; A. Chassot-Agostinho; R. S. Heist

Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: results from the GEOMETRY mono-1 study

J. Wolf, E. B. Garon, D. S. -W Tan, H. J. M. Groen, T. Seto, E. F. Smit, M. Zou, Y. Yang, Y. Li, A. Chassot-Agostinho, R. S. Heist

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	5-5
Aantal pagina's	1
Tijdschrift	Oncology Research and Treatment
Volume	44
Status	Published - sep.-2021

Handle.net

Permanente koppeling

Citeer dit

@article{5be71c6f950842199dcf1ec62c8e1b6c,

title = "Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: results from the GEOMETRY mono-1 study",

author = "J. Wolf and Garon, {E. B.} and Tan, {D. S. -W} and Groen, {H. J. M.} and T. Seto and Smit, {E. F.} and M. Zou and Y. Yang and Y. Li and A. Chassot-Agostinho and Heist, {R. S.}",

year = "2021",

month = sep,

language = "English",

volume = "44",

pages = "5--5",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "KARGER",

}

TY - JOUR

T1 - Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay

T2 - results from the GEOMETRY mono-1 study

AU - Wolf, J.

AU - Garon, E. B.

AU - Tan, D. S. -W

AU - Groen, H. J. M.

AU - Seto, T.

AU - Smit, E. F.

AU - Zou, M.

AU - Yang, Y.

AU - Li, Y.

AU - Chassot-Agostinho, A.

AU - Heist, R. S.

PY - 2021/9

Y1 - 2021/9

M3 - Meeting Abstract

VL - 44

SP - 5

EP - 5

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

ER -